161 related articles for article (PubMed ID: 19336541)
1. Absence of deleterious palladin mutations in patients with familial pancreatic cancer.
Klein AP; Borges M; Griffith M; Brune K; Hong SM; Omura N; Hruban RH; Goggins M
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1328-30. PubMed ID: 19336541
[TBL] [Abstract][Full Text] [Related]
2. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism.
Pogue-Geile KL; Chen R; Bronner MP; Crnogorac-Jurcevic T; Moyes KW; Dowen S; Otey CA; Crispin DA; George RD; Whitcomb DC; Brentnall TA
PLoS Med; 2006 Dec; 3(12):e516. PubMed ID: 17194196
[TBL] [Abstract][Full Text] [Related]
3. PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer.
Liotta L; Lange S; Maurer HC; Olive KP; Braren R; Pfarr N; Burger S; Muckenhuber A; Jesinghaus M; Steiger K; Weichert W; Friess H; Schmid R; Algül H; Jost PJ; Ramser J; Fischer C; Quante AS; Reichert M; Quante M
JCI Insight; 2021 Mar; 6(8):. PubMed ID: 33764904
[TBL] [Abstract][Full Text] [Related]
4. The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancer.
Zogopoulos G; Rothenmund H; Eppel A; Ash C; Akbari MR; Hedley D; Narod SA; Gallinger S
Hum Genet; 2007 Jun; 121(5):635-7. PubMed ID: 17415588
[TBL] [Abstract][Full Text] [Related]
5. Palladin mutation causes familial pancreatic cancer: absence in European families.
Slater E; Amrillaeva V; Fendrich V; Bartsch D; Earl J; Vitone LJ; Neoptolemos JP; Greenhalf W
PLoS Med; 2007 Apr; 4(4):e164. PubMed ID: 17455999
[No Abstract] [Full Text] [Related]
6. Familial pancreatic-cancer gene found.
Bradbury J
Lancet Oncol; 2007 Jan; 8(1):14. PubMed ID: 17348120
[No Abstract] [Full Text] [Related]
7. Polymorphism of the palladin gene and cardiovascular outcome in patients with atherosclerosis.
Hoke M; Schillinger M; Dick P; Exner M; Koppensteiner R; Minar E; Mlekusch W; Schlager O; Wagner O; Mannhalter C
Eur J Clin Invest; 2011 Apr; 41(4):365-71. PubMed ID: 21054356
[TBL] [Abstract][Full Text] [Related]
8. [Familial pancreatic cancer and the palladin gene: a new look at cancer mechanisms].
Gilgenkrantz S
Med Sci (Paris); 2007 Mar; 23(3):232-4. PubMed ID: 17349274
[No Abstract] [Full Text] [Related]
9. Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.
Shindo K; Yu J; Suenaga M; Fesharakizadeh S; Cho C; Macgregor-Das A; Siddiqui A; Witmer PD; Tamura K; Song TJ; Navarro Almario JA; Brant A; Borges M; Ford M; Barkley T; He J; Weiss MJ; Wolfgang CL; Roberts NJ; Hruban RH; Klein AP; Goggins M
J Clin Oncol; 2017 Oct; 35(30):3382-3390. PubMed ID: 28767289
[TBL] [Abstract][Full Text] [Related]
10. Absence of germline BRCA1 mutations in familial pancreatic cancer patients.
Axilbund JE; Argani P; Kamiyama M; Palmisano E; Raben M; Borges M; Brune KA; Goggins M; Hruban RH; Klein AP
Cancer Biol Ther; 2009 Jan; 8(2):131-5. PubMed ID: 19029836
[TBL] [Abstract][Full Text] [Related]
11. Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells.
Salaria SN; Illei P; Sharma R; Walter KM; Klein AP; Eshleman JR; Maitra A; Schulick R; Winter J; Ouellette MM; Goggins M; Hruban R
Cancer Biol Ther; 2007 Mar; 6(3):324-8. PubMed ID: 17404500
[TBL] [Abstract][Full Text] [Related]
12. Familial pancreatic cancer: hope can become truth.
Pezzilli R; Fantini L
JOP; 2007 Jan; 8(1):64-6. PubMed ID: 17228136
[No Abstract] [Full Text] [Related]
13. Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.
Bartsch DK; Langer P; Habbe N; Matthäi E; Chaloupka B; Sina M; Hahn SA; Slater EP
Clin Genet; 2010 Apr; 77(4):333-41. PubMed ID: 20041885
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer.
Martin ST; Matsubayashi H; Rogers CD; Philips J; Couch FJ; Brune K; Yeo CJ; Kern SE; Hruban RH; Goggins M
Oncogene; 2005 May; 24(22):3652-6. PubMed ID: 15806175
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families.
Slater EP; Langer P; Fendrich V; Habbe N; Chaloupka B; Matthäi E; Sina M; Hahn SA; Bartsch DK
Fam Cancer; 2010 Sep; 9(3):335-43. PubMed ID: 20195775
[TBL] [Abstract][Full Text] [Related]
16. Familial pancreatic cancer: from genes to improved patient care.
Hruban RH; Klein AP; Eshleman JR; Axilbund JE; Goggins M
Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):81-8. PubMed ID: 19072437
[TBL] [Abstract][Full Text] [Related]
17. Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.
Hu C; Hart SN; Polley EC; Gnanaolivu R; Shimelis H; Lee KY; Lilyquist J; Na J; Moore R; Antwi SO; Bamlet WR; Chaffee KG; DiCarlo J; Wu Z; Samara R; Kasi PM; McWilliams RR; Petersen GM; Couch FJ
JAMA; 2018 Jun; 319(23):2401-2409. PubMed ID: 29922827
[TBL] [Abstract][Full Text] [Related]
18. BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group.
Cho JH; Bang S; Park SW; Chung JB; Song SY
Pancreas; 2008 May; 36(4):337-40. PubMed ID: 18437078
[TBL] [Abstract][Full Text] [Related]
19. MEFV gene 3'-UTR Alu repeat polymorphisms in patients with familial Mediterranean fever.
Ustek D; Ekmekçi C; Oku B; Coşan F; Cakiris A; Abaci N; Celik S; Kamali S; Hatemi G; Kasapçopur O; Ozdoğan H; Gül A
Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S72-6. PubMed ID: 19026119
[TBL] [Abstract][Full Text] [Related]
20. CDKN2A germline mutations in familial pancreatic cancer.
Bartsch DK; Sina-Frey M; Lang S; Wild A; Gerdes B; Barth P; Kress R; Grützmann R; Colombo-Benkmann M; Ziegler A; Hahn SA; Rothmund M; Rieder H
Ann Surg; 2002 Dec; 236(6):730-7. PubMed ID: 12454511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
